Global Antimicrobial Peptides Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032

Market Overview

According to DIResearch＇s in-depth investigation and research, the global Antimicrobial Peptides market size will reach 6.92 Million USD in 2025 and is projected to reach 10.01 Million USD by 2032, with a CAGR of 5.42% (2025-2032). Notably, the China Antimicrobial Peptides market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be  Million USD, representing approximately  % of the global market share.

Research Summary

Antimicrobial peptides (AMPs) are small protein molecules, produced naturally by the immune system of a wide range of organisms, including humans, animals, plants, and bacteria. These peptides act as natural antibiotics, antimicrobial and host-defense agents against a wide range of pathogens, including bacteria, viruses, fungi, and parasites, by disrupting their cell membranes and walls. AMPs have a broad-spectrum antimicrobial activity, low toxicity, and rapid action, making them a promising alternative to traditional antibiotics, which are becoming increasingly ineffective due to microbial resistance. AMPs are also known as host defense peptides (HDPs), cationic antimicrobial peptides (CAPs), or simply antimicrobial peptides (APs).

The major global suppliers of Antimicrobial Peptides include AnaSpec, AMP Biotech, Phoenix Biotech, Novabiotics, Chinese Peptide, Ontores, GenScript, Hycult Biotech, Sunsmile, Ruixing Biotechnology, Zhongnong Yingtai Biotechnology, Glam Technology, ProteLight Pharmaceutical & Biotechnology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Antimicrobial Peptides. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Antimicrobial Peptides market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Antimicrobial Peptides market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Antimicrobial Peptides industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Antimicrobial Peptides Include:

AnaSpec

AMP Biotech

Phoenix Biotech

Novabiotics

Chinese Peptide

Ontores

GenScript

Hycult Biotech

Sunsmile

Ruixing Biotechnology

Zhongnong Yingtai Biotechnology

Glam Technology

ProteLight Pharmaceutical & Biotechnology

Antimicrobial Peptides Product Segment Include:

Plant Antimicrobial Peptides

Microbial Antimicrobial Peptides

Animal Antimicrobial Peptides

Antimicrobial Peptides Product Application Include:

Pharmaceuticals

Feed Additives

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend

Chapter 2: Global Antimicrobial Peptides Industry PESTEL Analysis

Chapter 3: Global Antimicrobial Peptides Industry Porter's Five Forces Analysis

Chapter 4: Global Antimicrobial Peptides Major Regional Market Size (Revenue) and Forecast Analysis

Chapter 5: Global Antimicrobial Peptides Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 6: Global Antimicrobial Peptides Revenue and Forecast Analysis by Product Type

Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 8: Industrial Chain Analysis, Antimicrobial Peptides Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis

Chapter 9: Research Findings and Conclusion

Chapter 10: Methodology and Data Sources